JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Scope & Guideline

Elevating standards in oncology pharmacy for a healthier tomorrow.

Introduction

Immerse yourself in the scholarly insights of JOURNAL OF ONCOLOGY PHARMACY PRACTICE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1078-1552
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1995 to 2024
AbbreviationJ ONCOL PHARM PRACT / J. Oncol. Pharm. Pract.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The JOURNAL OF ONCOLOGY PHARMACY PRACTICE focuses on optimizing pharmaceutical care in oncology, emphasizing the intersection of pharmacotherapy, patient safety, and clinical practice within cancer care. The journal aims to improve patient outcomes by disseminating research that addresses medication management, adverse drug reactions, and innovative pharmacy practices in oncology settings.
  1. Pharmaceutical Care in Oncology:
    The journal emphasizes the role of pharmacists in providing comprehensive medication management, ensuring safe and effective use of anticancer therapies, and enhancing patient education.
  2. Adverse Drug Reactions and Toxicity Management:
    Research on the identification, prevention, and management of adverse drug reactions related to cancer therapies, focusing on improving patient safety and quality of life.
  3. Clinical Pharmacy Interventions:
    The journal highlights studies on clinical pharmacy interventions, including medication reconciliation, therapeutic drug monitoring, and the integration of clinical pharmacists in oncology teams.
  4. Pharmacotherapy Research:
    The focus includes pharmacotherapy outcomes, including efficacy and safety of various cancer treatments, comparative effectiveness studies, and advancements in drug regimens.
  5. Patient-Centered Care:
    Research related to patient experience, adherence to medication, and the impact of educational interventions on cancer patients' knowledge and management of their therapies.
  6. Innovative Pharmacy Practices:
    Exploration of new methodologies in pharmacy practice, including the use of technology, telepharmacy, and automation in medication management for oncology patients.
The JOURNAL OF ONCOLOGY PHARMACY PRACTICE has increasingly shifted its focus towards emerging themes that reflect current challenges and advancements in oncology pharmacy. This trend showcases the journal's commitment to addressing contemporary issues in cancer care.
  1. Immunotherapy and Targeted Therapies:
    There is a growing emphasis on research related to immunotherapy and targeted therapies, reflecting their increasing use and complexity in cancer treatment.
  2. Pharmacogenomics and Personalized Medicine:
    Research into pharmacogenomics is on the rise, focusing on how genetic variations affect patient responses to cancer medications, promoting personalized treatment strategies.
  3. Telepharmacy and Remote Care:
    The incorporation of telepharmacy in oncology has gained traction, particularly in light of the COVID-19 pandemic, facilitating remote patient monitoring and medication management.
  4. Patient Education and Engagement:
    An increased focus on the importance of patient education and engagement strategies that enhance adherence and understanding of treatment protocols is evident.
  5. Management of Adverse Effects:
    Emerging research is increasingly centered on strategies to manage and mitigate adverse effects associated with modern cancer therapies, including immune-related adverse events.
  6. Cost-Effectiveness Studies:
    There is an upward trend in studies assessing the economic impact of cancer therapies, emphasizing the need for cost-effective treatment options in oncology.

Declining or Waning

In recent years, certain themes within the JOURNAL OF ONCOLOGY PHARMACY PRACTICE have seen a decline in focus, likely reflecting shifts in research priorities and emerging trends in oncology pharmacy practice.
  1. Traditional Chemotherapy Protocols:
    Research focused specifically on traditional chemotherapy regimens appears to be declining as newer targeted therapies and immunotherapies gain prominence.
  2. Single-Agent Studies:
    There is a noticeable decrease in publications centered on single-agent chemotherapy studies, as multi-agent and combination therapies become the focus of clinical research.
  3. Pharmacy Practice Guidelines:
    While guidelines remain important, there is a shift away from generic pharmacy practice guidelines towards more specific, evidence-based protocols tailored to individual patient needs.
  4. Focus on Pharmacokinetics Alone:
    Research that solely emphasizes pharmacokinetic studies without considering pharmacodynamics and clinical outcomes has seen less attention as a more holistic approach gains traction.
  5. Limited Scope on Complementary Therapies:
    Interest in complementary and alternative medicine approaches in oncology has waned, with a stronger emphasis on evidence-based pharmacotherapy.

Similar Journals

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Empowering research in pharmacy and pharmaceutical sciences.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

International Journal of Pharmaceutical Investigation

Driving Innovation in Drug Development and Formulation
Publisher: INPHARM ASSOC, PHCOG NETISSN: 2230-973XFrequency: 4 issues/year

International Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.

Current Issues in Pharmacy and Medical Sciences

Connecting researchers to the pulse of medical advancements.
Publisher: SCIENDOISSN: 2084-980XFrequency: 4 issues/year

Current Issues in Pharmacy and Medical Sciences is a prominent open-access journal published by SCIENDO, dedicated to advancing knowledge and understanding in the fields of pharmacy, biochemistry, molecular biology, and medicine. With an ISSN of 2084-980X and an E-ISSN of 2300-6676, this journal provides a platform for researchers and academics to disseminate current findings and methodologies shaping the future of these disciplines. Since its inception in 2012 and having established itself as an open-access journal since 2014, Current Issues in Pharmacy and Medical Sciences has been committed to providing high-quality, peer-reviewed content that fosters innovation and scholarly collaboration, even as it currently ranks in the Q4 category across several key areas, including Pharmacology and Biochemistry. The journal's findings are particularly relevant to professionals and students aiming to stay abreast of the latest trends and issues impacting healthcare and pharmaceutical sciences. With future issues anticipated until 2024, this journal is positioned as a vital resource for anyone engaged in the pharmaceutical and medical fields and contributing to meaningful advancements.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Advancing pharmacy practice through impactful research.
Publisher: OXFORD UNIV PRESS INCISSN: 1079-2082Frequency: 24 issues/year

American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.

International Journal of Clinical Pharmacy

Fostering Global Collaboration in Clinical Pharmacy
Publisher: SPRINGERISSN: 2210-7703Frequency: 6 issues/year

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

Journal of Pharmaceutical Policy and Practice

Bridging the gap between research and pharmaceutical practice.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

JOURNAL OF PHARMACY TECHNOLOGY

Connecting researchers and practitioners in pharmacy technology.
Publisher: SAGE PUBLICATIONS INCISSN: 8755-1225Frequency: 6 issues/year

JOURNAL OF PHARMACY TECHNOLOGY is a premier publication in the field of Pharmaceutical Science, established in 1989 and published by SAGE PUBLICATIONS INC. This journal serves as an essential resource for professionals, researchers, and students dedicated to the advancements in pharmacy technology and the application of innovative solutions in pharmaceutical practices. With an ISSN of 8755-1225 and an E-ISSN of 1549-4810, the journal provides a rigorous peer-reviewed platform for disseminating cutting-edge research and case studies. As of 2023, it is ranked Q3 in the Scopus categories of Pharmacology, Toxicology, and Pharmaceutics, highlighting its relevance in the field. Although it currently does not offer an Open Access option, JOURNAL OF PHARMACY TECHNOLOGY aims to remain a critical avenue for scholarly communication and knowledge dissemination among practitioners in the pharmaceutical sector, ensuring they stay informed of the latest trends and findings that impact their work.

Exploratory Research in Clinical and Social Pharmacy

Fostering collaboration in the evolving pharmacy landscape.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

Journal of Research in Pharmacy Practice

Advancing pharmaceutical excellence through innovative research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2319-9644Frequency: 4 issues/year

Journal of Research in Pharmacy Practice, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a premier open-access journal dedicated to advancing the field of pharmaceutical sciences through rigorous research and innovative practices. Since its inception, the journal has aimed to bridge gaps between pharmacy practice and research, providing a platform for researchers, professionals, and students alike to disseminate their findings and insights. With a commitment to high-quality, peer-reviewed content, the journal covers a wide array of topics including clinical pharmacy, medication management, and healthcare policies, contributing to the enhancement of global healthcare practices. The journal is easily accessible online, having embraced an open-access model since 2012, ensuring that valuable research is freely available to all. Engaging with the Journal of Research in Pharmacy Practice not only facilitates knowledge exchange but also aids in the continuous evolution of pharmacy practice, emphasizing its critical role in healthcare delivery and patient outcomes.

Pharmacy Practice-Granada

Fostering collaboration to elevate pharmacy education and practice.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.